The following is a summary of “Hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24,” published in the January 2025 issue of ...

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

On the fifth anniversary of the U.S. declaring a public health emergency over COVID-19, people continue to lose their lives.

Leukocyte count an independent predictor of postacute sequelae of severe acute respiratory coronavirus 2 infection in postmenopausal women.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

The risk of developing RDS was significantly increased among newborns born to mothers with confirmed COVID-19 infection during pregnancy.

The “Epicovid 2.0” study shows that the “impacts of the pandemic are great and long-lasting” and that it has “exacerbated ...

The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...

Researchers found that COVID-19 is linked to increased biomarkers associated with Alzheimer’s disease, particularly in those ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...